X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiac & cardiovascular systems (33) 33
index medicus (32) 32
humans (26) 26
abridged index medicus (20) 20
female (20) 20
male (20) 20
middle aged (19) 19
aged (18) 18
acute coronary syndromes (15) 15
heart attacks (15) 15
stroke (15) 15
ezetimibe (14) 14
cholesterol (13) 13
clinical trials (13) 13
double-blind method (13) 13
risk factors (13) 13
cardiovascular (12) 12
peripheral vascular disease (12) 12
internal medicine (11) 11
mortality (11) 11
treatment outcome (11) 11
cardiovascular diseases (10) 10
prevention (10) 10
secondary prevention (10) 10
simvastatin (10) 10
analysis (9) 9
atherosclerosis (9) 9
cardiovascular disease (9) 9
diabetes (9) 9
dosage and administration (9) 9
risk (9) 9
acute coronary syndrome (8) 8
c-reactive protein (8) 8
care and treatment (8) 8
health risk assessment (8) 8
lipids (8) 8
medicine, general & internal (8) 8
myocardial infarction (8) 8
usage (8) 8
cardiology (7) 7
drug therapy (7) 7
efficacy (7) 7
heart attack (7) 7
heart failure (7) 7
myocardial-infarction (7) 7
outcomes (7) 7
patients (7) 7
safety (7) 7
angina pectoris (6) 6
cardiac patients (6) 6
cerebral infarction (6) 6
cholesterol, ldl - blood (6) 6
diabetes mellitus (6) 6
disease prevention (6) 6
drug therapy, combination (6) 6
heart diseases (6) 6
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (6) 6
myocardial infarction - prevention & control (6) 6
risk assessment (6) 6
acute coronary syndrome - drug therapy (5) 5
atorvastatin (5) 5
heart-disease (5) 5
inflammation (5) 5
metaanalysis (5) 5
obesity (5) 5
simvastatin - therapeutic use (5) 5
statin therapy (5) 5
statins (5) 5
angina (4) 4
anticholesteremic agents - therapeutic use (4) 4
arteriosclerosis (4) 4
association (4) 4
biomarkers (4) 4
biomarkers - blood (4) 4
body mass index (4) 4
body weight (4) 4
cancer (4) 4
cardiovascular diseases - mortality (4) 4
cholesterol, ldl (4) 4
coronary artery bypass (4) 4
coronary heart disease (4) 4
coronary vessels (4) 4
disease (4) 4
events (4) 4
ezetimibe - therapeutic use (4) 4
fda approval (4) 4
health risks (4) 4
hypertension (4) 4
low-density lipoprotein cholesterol (4) 4
medical colleges (4) 4
myocardial ischemia (4) 4
research (4) 4
acute coronary syndrome - blood (3) 3
acute coronary syndrome - diagnosis (3) 3
acute myocardial-infarction (3) 3
anticholesteremic agents (3) 3
atherosclerosis - blood (3) 3
atherosclerosis - drug therapy (3) 3
bariatric surgery (3) 3
c-reactive protein - analysis (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 08/2017, Volume 70, Issue 9, p. 1200
Journal Article
Clinical Chemistry and Laboratory Medicine (CCLM), ISSN 1434-6621, 06/2019, Volume 57, Issue 7, pp. 1084 - 1092
Background Growth differentiation factor (GDF)-15 has been shown to predict cardiovascular (CV) outcomes in acute coronary syndrome (ACS) using non-commercial... 
heart failure | cardiovascular death | automated assay | growth differentiation factor 15 | GDF-15 | Heart | Renal function | Diabetes mellitus | Mortality | Risk | Assaying | Elevation | Body mass | Measurement methods | Death | Heart diseases | Continuity (mathematics) | Smoking
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 13, pp. 2139 - 2139
  Conclusions In stable patients with a history of MI, ischemic stroke, or PAD, a combination of clinical and laboratory characteristics identify patients at... 
Cardiovascular | Internal Medicine | Angina pectoris | Stroke
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At... 
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Liver | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
Circulation, ISSN 0009-7322, 07/2016, Volume 134, Issue 1, pp. 24 - 36
Journal Article
Circulation, ISSN 0009-7322, 2015, Volume 132, Issue 13, pp. 1224 - 1233
Journal Article
JAMA, ISSN 0098-7484, 09/2016, Volume 316, Issue 10, pp. 1045 - 1047
Journal Article
Critical Care Medicine, ISSN 0090-3493, 12/2014, Volume 42, p. A1401
Journal Article